Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Response Treatment for Children With Autism Spectrum Disorders

NCT01908686 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT01908686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01908686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Response Treatment for Children With Autism Spectrum Disorders
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2012
Completion date
March 1, 2020
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorders